国务院：将中国（江苏）自由贸易试验区打造成为具有世界影响力的生物医药产业集聚地

Core Viewpoint - The State Council has approved the "Development Plan for Open Innovation of the Entire Biopharmaceutical Industry Chain in the China (Jiangsu) Pilot Free Trade Zone," aiming to enhance the region's global influence and competitiveness in the biopharmaceutical sector [1][2]. Group 1: Key Objectives - The plan emphasizes the need for steady progress while fully implementing new development concepts, accelerating the construction of a new development pattern, and promoting high-quality development [1]. - It aims to establish the China (Jiangsu) Pilot Free Trade Zone as a world-class biopharmaceutical industry hub and a high ground for innovative development [1][2]. Group 2: Strategic Focus Areas - The plan identifies seven key tasks across various aspects, including enhancing R&D innovation capabilities, improving product approval services, constructing production and circulation systems, and strengthening support for essential resources [2]. - By 2030, the plan targets rapid growth in the biopharmaceutical industry scale, continuous optimization of the innovation ecosystem, significant modernization of the industry chain, and substantial improvements in openness and safety assurance capabilities [2]. Group 3: Implementation and Collaboration - The plan is a significant outcome of the strategy to enhance the pilot free trade zone, assigning new reform pilot tasks to the China (Jiangsu) Pilot Free Trade Zone [2]. - The Ministry of Commerce will collaborate with the Jiangsu provincial government and relevant departments to strengthen regulatory coordination and ensure the implementation of the plan's reform tasks [2].